Abstract
HTA165 Unmet Medical Need in Norwegian Clinical Practice and Cost-Effectiveness Analysis of Polatuzumab in Combination With R-CHP Compared to R-CHOP in Patients With Previously Untreated DLBCL With an IPI Score of Three and Above
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
